Why is Aarti Drugs falling/rising?

As of 25-Jul, Aarti Drugs Ltd's stock price is currently at Rs 533.00, reflecting a decrease of Rs 5.1 or 0.95%. Today, the stock underperformed its sector by 1.12%, despite reaching an intraday high of Rs 551.1, which represents a 2.42% increase at that point. Over the past week, the stock has shown a positive return of 1.92%, and over the past month, it has significantly outperformed the benchmark with a return of 17.93% compared to the Sensex's decline of 1.56%. However, the stock's delivery volume has fallen sharply by 52.04% against the 5-day average, indicating a decrease in investor participation. Despite these fluctuations, the company maintains a high management efficiency with a return on capital employed (ROCE) of 17.84% and a low debt-to-equity ratio, which supports its valuation. In the broader market context, Aarti Drugs has demonstrated resilience with a year-to-date return of 15.71%, while the Sensex has only increased by 4.25%. This indicates that the stock has been performing well relative to the overall market. However, the recent decline in price may be attributed to the drop in trading volume and investor participation, which could signal a lack of confidence among investors despite the company's strong fundamentals and attractive valuation metrics. Overall, while the stock has shown positive long-term performance, the current price movement reflects short-term challenges that may be affecting investor sentiment.